CLCR Call: July 26, 2021

For Public Health

At a glance

The July 26, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on the SARS-CoV-2 variants and genomic changes, as well as an FDA update.

Format: MP3
Language: English (US)
Size: 29 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome: Nancy Anderson, CDC Division of Laboratory Systems (DLS)

CDC Influenza SARS-CoV-2 Multiplex Assay: Brandi Limbago, CDC Laboratory and Testing Task Force for the COVID-19 Response

Genomic Changes Causing SARS-CoV-2 Detection Partial Failure: Daniel D. Rhoads, Cleveland Clinic

FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)

Meeting materials

Content Source
About this page
Published: November 20, 2024
Updated: July 26, 2021

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: July 26, 2021

The information on this page was last reviewed by subject matter experts to ensure accuracy.